Flyte Aviation, Inc.
Fort Mill, South Carolina, United States · Aerospace, Air Transportation, Biotechnology
Catheter Precision, Inc. is a U.S.-based innovative medical device company focused on electrophysiology products, bringing new solutions to market to improve the treatment of cardiac arrhythmias. It is committed to developing groundbreaking technology for electrophysiology procedures by collaborating with physicians and continuously advancing its products.
Key facts
- Headquarters
- Fort Mill, South Carolina, United States
- Employees
- Unknown
- Industries
- Aerospace, Air Transportation, Biotechnology
- Status
- Public (VJET)
- Website
- flyteaviation.com
Recent activity at Flyte Aviation, Inc.
- : Flyte Aviation has launched the Flyte Partner Portal, a digital platform aimed at enhancing B2B partnerships in private aviation.
- : Flyte Aviation Enters Multi-Year Partnership as the Official Private Aviation Partner of the Philadelphia 76ers.
- : SEC 8-K (7.01): On October 14, 2026, Flyte Aviation, Inc. announced a multi-year partnership with the Philadelphia 76ers, establishing itself as the Official Private Aviation Partner of the team. This strategic alliance aims to enhance the 76ers' travel capabilities and provide premium aviation services during the NBA season. The announcement, detailed in a press release attached as Exhibit 99.1, underscores Flyte Aviation's commitment to expanding its brand presence and market reach through partnerships with major sports franchises. The partnership is expected to strengthen the company's visibility and could lead to increased business opportunities in the sports sector.
- : SEC 8-K (8.01): On October 9, 2026, Flyte Aviation, Inc. entered into a material definitive agreement with existing investors to purchase 2,050 shares of Series C-4 Convertible Preferred Stock, resulting in gross proceeds of $2.05 million. This agreement is executed pursuant to the Additional Investment Right outlined in a prior Securities Purchase Agreement dated March 9, 2026. The closing of this transaction is anticipated to occur on or about October 13, 2026, once customary closing conditions are fulfilled. This capital infusion is expected to provide Flyte Aviation with additional financial resources to support its growth initiatives.
- : SEC 8-K (7.01): On October 5, 2026, Flyte Aviation, Inc., formerly known as Catheter Precision, Inc., issued a press release announcing its launch under the new ticker symbol 'VJET' on the NYSE American. This marks a significant branding change for the company and is aimed at enhancing its market presence. The timing of this launch is strategic, coinciding with their operational and marketing initiatives to attract investors and customers alike. The release indicates that this rebranding aligns with the company's growth objectives and future plans, effective immediately following the change announced earlier on this date.
- : SEC 8-K (5.02): On September 30, 2026, during the Annual Meeting of stockholders for Catheter Precision, Inc., shareholders approved an amendment to the 2023 Equity Incentive Plan, increasing the number of shares reserved by 5,000,000. Additionally, a one-time repricing of stock options was approved, where options with exercise prices above the Fair Market Value of $0.152 per share were adjusted accordingly. This repricing affects options held by key executives including David A. Jenkins and Philip Anderson, aligning their options with other employees and consultants. These actions demonstrate the company's strategy to incentivize talent by adjusting compensation plans to current market conditions.
- : SEC 8-K (8.01): On September 24, 2026, Catheter Precision, Inc. approved an amendment to their Amended and Restated Certificate of Incorporation, changing the company's name to Flyte Aviation, Inc. and effecting a 1-for-10 reverse stock split of its common stock. The name change was initiated by the Board without requiring stockholder approval, while the reverse stock split had been previously authorized at a special meeting. This restructuring is set to take effect on October 5, 2026, impacting the trading of their common stock, which will commence under the new ticker symbol 'VJET' on NYSE American.
- : SEC 8-K (3.02): On July 15, 2026, Catheter Precision, Inc. completed the closing of its issuance of 3,470 shares of Series C-3 Convertible Preferred Stock, each with a stated value of $1,000, totaling gross proceeds of approximately $3.47 million. This transaction was executed as part of a previously disclosed Securities Purchase Agreement from February 6, 2026, involving multiple investors. The issuance will provide the company with additional capital for its operations. The effective date of the transaction aligns with the filing date, confirming the event's recency and relevance.
- : Catheter Precision Inc. announces partnership with GSE Worldwide to enhance its heart failure technologies.
- : SEC 8-K (1.01): On June 7, 2026, Catheter Precision, Inc. entered into a Securities Purchase Agreement with Volato Group, Inc. for the purchase of 2,941,176 shares of common stock at $0.34 per share, totaling $1,000,000. The transaction is part of a private placement, with customary closing conditions including the absence of a Material Adverse Effect on Volato. Additionally, a Registration Rights Agreement was executed on the same date, requiring Volato to file a registration statement for the resale of the shares within 10 days to the SEC, illustrating a strategic financing relationship and potential future liquidity for Catheter Precision. The agreement includes representations, warranties, and indemnification provisions aimed at protecting the interests of the parties involved.
Flyte Aviation, Inc. funding history
| Date | Round | Amount |
|---|---|---|
| Jun 2026 | Post-IPO Equity | $1.0M |
| Feb 2026 | Funding Round | $36.5M |
| May 2025 | Private Equity | $1.5M |
| Apr 2023 | Venture | $8.0M |
| Aug 2022 | Venture | $6.2M |
Leadership
- Joan Stafslien, Director
- Susanne Meline, Director
- Richard Mejia, Director
- Martin Colombatto, Director
- Will McGuire, Executive Officer, Director
- Maurice Buchbinder, Director
- Martin Burstein, Director
- Richard Heymann, Director
- Melissa Burstein, Executive Officer, Director
- Dean Irwin, Executive Officer, Director
Verified email and direct lines for Flyte Aviation, Inc.’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Companies similar to Flyte Aviation, Inc.
- Scarlet · Biotechnology, Health Care, Manufacturing, Medical, Medical Device
- ENvue Medical, Inc. · Biotechnology, Health Care, Manufacturing, Medical, Medical Device
- Capitan Orthopedics · Biotechnology, Health Care, Manufacturing, Medical, Medical Device
- Picard Medical · Biotechnology, Health Care, Manufacturing, Medical, Medical Device
- Integris Medtech · Biotechnology, Health Care, Manufacturing, Medical, Medical Device
About Flyte Aviation, Inc.: questions and answers
What does Flyte Aviation, Inc. do?
Catheter Precision, Inc. is a U.S.-based innovative medical device company focused on electrophysiology products, bringing new solutions to market to improve the treatment of cardiac arrhythmias. It is committed to developing groundbreaking technology for electrophysiology procedures by collaborating with physicians and continuously advancing its products.
Where is Flyte Aviation, Inc. headquartered?
Flyte Aviation, Inc. is headquartered in Fort Mill, South Carolina, United States.
Has Flyte Aviation, Inc. raised funding?
Yes. Fundz has recorded 5 funding events for Flyte Aviation, Inc.. The most recent, Post-IPO Equity of $1.0M, was in Jun 2026.
What is the latest news on Flyte Aviation, Inc.?
On Oct 21, 2026, Flyte Aviation has launched the Flyte Partner Portal, a digital platform aimed at enhancing B2B partnerships in private aviation.
Is Flyte Aviation, Inc. a public company?
Yes. Flyte Aviation, Inc. is publicly traded under the ticker VJET.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy